NextGen's 2010 Revenues Improve 4 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein biomarker and assay development firm NextGen Group announced on Friday that 2010 revenues increased 4 percent to a little more $1.2 million.

That compares to 2009 revenues of slightly less than $1.2 million.

For the year, the UK-based firm's net loss improved 8 percent to $3.3 million, or $.06 per share, from $3.6 million, $.11 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.